KYG4818G1010
KYG4818G1010
INNOVENT BIO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 13.041.523.000 | 9.421.888.000 | 38.4% |
| Cost of Revenue | 1.756.019.000 | 1.510.210.000 | 16.3% |
| Gross Profit | 11.285.504.000 | 7.911.678.000 | 42.6% |
| 9.144.591.000 | 7.653.559.000 | 19.5% | |
| Operating Income | 2.140.913.000 | 258.119.000 | 729.4% |
| Pretax Income | 838.924.000 | -78.621.000 | 1167.0% |
| Net Income Common Stockholders | 813.565.000 | -94.631.000 | 959.7% |
| -- | -- | -- | |
| -- | -- | -- |